Rick Perry urges regulated access to ibogaine after Texas funds FDA trials and veterans report recovery from trauma and addiction

Ibogaine, a psychedelic derived from an African shrub, is presented as a potential treatment for trauma, substance use disorder, and brain injury. Rick Perry argues that fear based messaging about psychedelics kept the U.S. from exploring therapies that could save lives, and he points to Texas allocating $50 million for FDA approved clinical trials of ibogaine as a major shift toward regulated research. Perry credits personal stories from Navy SEALs Morgan and Marcus Luttrell who reportedly pursued ibogaine treatment in Mexico and returned with reduced opioid dependence and improved functioning. He also frames ibogaine as working differently from standard addiction options by potentially interrupting long term dependence after medically supervised dosing. He emphasizes that ibogaine is not risk free, especially for heart health, and calls for screening, cardiac monitoring, and clinical protocols to mitigate danger while more large scale research is still needed.